- Report
- May 2025
- 191 Pages
Global
From €3175EUR$3,545USD£2,707GBP
€3528EUR$3,939USD£3,008GBP
- Report
- June 2025
- 93 Pages
Global
From €5240EUR$5,850USD£4,467GBP
- Report
- April 2025
- 250 Pages
Global
From €4022EUR$4,490USD£3,428GBP
- Report
- June 2025
- 384 Pages
Global
From €5240EUR$5,850USD£4,467GBP
- Report
- April 2025
- 200 Pages
Global
From €4022EUR$4,490USD£3,428GBP
- Report
- June 2025
- 83 Pages
United States
From €2665EUR$2,975USD£2,271GBP
€3135EUR$3,500USD£2,672GBP
- Report
- April 2024
- 185 Pages
Global
From €3426EUR$3,825USD£2,920GBP
€4031EUR$4,500USD£3,436GBP
- Book
- August 2022
- 672 Pages
- Book
- August 2022
- 736 Pages
- Book
- April 2021
- 592 Pages
- Book
- August 2011
- 466 Pages

Patient Blood Management (PBM) is a medical strategy that focuses on optimizing the care of patients who require blood transfusions. It is a multidisciplinary approach that involves the use of evidence-based practices to reduce the need for allogeneic blood transfusions, while ensuring the safety of the patient. PBM includes strategies such as preoperative anemia management, intraoperative blood salvage, and the use of alternative blood products. It also involves the use of blood conservation techniques such as cell salvage, erythropoietin, and iron supplementation.
PBM is an important part of blood banking, as it helps to reduce the demand for allogeneic blood transfusions and improve patient outcomes. It is also beneficial to blood banks, as it helps to reduce the cost of blood products and improve the efficiency of the blood supply.
Some companies in the PBM market include Fresenius Kabi, Haemonetics Corporation, Terumo BCT, and Grifols. Show Less Read more